AMSilk establishes Scientific Advisory Board
AMSilk GmbH presents its newly established Scientific Advisory Board. Consisting of the three internationally renowned scientists Prof. Dr. Scheibel, Prof. Dr. Fansa and Prof. Dr. Weuster-Botz, the Board will provide scientific advisory support to AMSilk. AMSilk is focusing on the application of its proprietary high-performance silk biopolymers in the fields of medical technology, personal care products as well as industrial applications and textiles.
Prof. Dr. Thomas Scheibel is full Professor at the University of Bayreuth, where he holds the chair for Biomaterials. As co-founder of AMSilk and inventor of the synthetic silk biopolymer production technology his expertise is highly valued in all aspects concerning the research around spider silk and beyond. After completing his doctorate at the University of Regensburg/Germany in 1998 he conducted scientific work at the University of Chicago and the Technical University Munich. In 2007 he became professor at the University of Bayreuth.
Prof. Dr. Hisham Fansa is an internationally renowned plastic and aesthetic surgeon with over 25 years of experience and co-owner of the Heitmann-Fansa Aesthetic Medicine Practice in Munich. From 2011 until 2013 Prof. Fansa was the President of the German Society of Wound Healing and Treatment (DGfW). In 2013 he was elected Vice President of the German Society of Plastic, Reconstructive and Aesthetic Surgeons (DGPRÄC) and German delegate for the European Association of Plastic Surgeons (EURAPS). Prof. Fansa graduated from the Medical University in Hannover/Germany in 1994. As a highly experienced surgeon he serves as consultant for all medical technology activities of AMSilk. AMSilk’s current development projects include breast implants featuring an AMSilk biopolymer coating.
Prof. Dr. Dirk Weuster-Botz is full professor at the Institute of Biochemical Engineering of the Technical University Munich (TUM) since 2000. In 2014 he became director of the TUM Research Center for Industrial Biotechnology. After studying chemical engineering at the University of Karlsruhe/Germany, he received a doctorate from the Research Center in Jülich/Germany and became a professor at RWTH in Aachen/Germany. Especially his strong expertise in industrial biotechnology and bacterial production systems is of great value for AMSilk.
Other news from the department people
Most read news
More news from our other portals
Last viewed contents
IDT Biologika Establishes New Corporation in the United States
Evotec Extends Medicinal Chemistry Collaboration with Ono Pharmaceutical
Revolutionary new insights into blood vessel formation in cancer - Research opens new avenue for cancer therapy
Antisense Pharma Obtains IND for Clinical Studies in the USA - The American Department of Health, the FDA, agrees to the use of trabedersen for high-grade glioma (malignant brain tumor)
Novel antibiotics in the fight against antimicrobial resistance - SANTERO announces a €8 million Series A funding round led by Newton Biocapital
KÖTTERMANN finds an investor
Combination Therapy against Cancer - Synergistic anticancer therapy with two cell killer agent systems in one nanocapsule
QUANTRO Therapeutics receives important Austrian research funding to further develop its platform for the discovery of novel cancer therapies - Austrian Research Promotion Agency FFG awards funding to QUANTRO to accelerate the next development phase of the company's proprietary research platform
Max-Planck-Institut für Entwicklungsbiologie - Tübingen, Germany
